{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:00Z","timestamp":1791222060384,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100016334","name":"Jiangsu Provincial Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203659"],"award-info":[{"award-number":["82203659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472862"],"award-info":[{"award-number":["82472862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472938"],"award-info":[{"award-number":["82472938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272791"],"award-info":[{"award-number":["82272791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jhep.2025.02.045","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:54:41Z","timestamp":1743123281000},"page":"712-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma"],"prefix":"10.1016","volume":"83","author":[{"given":"Suiqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2419-4426","authenticated-orcid":false,"given":"Yue","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jhep.2025.02.045_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.31424","article-title":"Local and regional therapies for hepatocellular carcinoma","volume":"73","author":"Kloeckner","year":"2021","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jhep.2025.02.045_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhep.2025.02.045_bib3","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.02.045_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.02.045_bib5","article-title":"Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids","volume":"8","author":"Zhao","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhep.2025.02.045_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jhep.2025.02.045_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.02.045_bib8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.02.045_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.02.045_bib10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2023.03.017","article-title":"Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners","volume":"35","author":"Li","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.02.045_bib11","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jhep.2025.02.045_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2023.08.029","article-title":"Bioactive signalling lipids as drivers of chronic liver diseases","volume":"80","author":"Kaffe","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.045_bib13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPARalpha pathways","volume":"63","author":"Li","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.045_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2025.02.045_bib15","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.02.045_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228467","article-title":"Pivotal role of fatty acid synthase in c-MYC driven hepatocarcinogenesis","volume":"21","author":"Jia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2025.02.045_bib17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","article-title":"USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma","volume":"13","author":"Ning","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.045_bib18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-024-46413-6","article-title":"Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics","volume":"15","author":"Zhong","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.045_bib19","doi-asserted-by":"crossref","first-page":"W71","DOI":"10.1093\/nar\/gkq329","article-title":"MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data","volume":"38","author":"Xia","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2025.02.045_bib20","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1097\/HEP.0000000000000314","article-title":"Hepatic mitochondrial NAD + transporter SLC25A47 activates AMPKalpha mediating lipid metabolism and tumorigenesis","volume":"78","author":"Cheng","year":"2023","journal-title":"Hepatol (Baltimore, Md"},{"key":"10.1016\/j.jhep.2025.02.045_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2023.03.041","article-title":"HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia","volume":"79","author":"Povero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.02.045_bib22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.02.045_bib23","article-title":"eIF3f mediates SGOC pathway reprogramming by enhancing deubiquitinating activity in colorectal cancer","volume":"10","author":"Pan","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhep.2025.02.045_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000545","article-title":"The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation","volume":"8","author":"Moretti","year":"2010","journal-title":"Plos Biol"},{"key":"10.1016\/j.jhep.2025.02.045_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","article-title":"An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.045_bib26","article-title":"GPS-Uber: a hybrid-learning framework for prediction of general and E3-specific lysine ubiquitination sites","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jhep.2025.02.045_bib27","article-title":"Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhep.2025.02.045_bib28","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","article-title":"ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.045_bib29","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2025.02.045_bib30","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/s41467-018-07620-0","article-title":"SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4","volume":"9","author":"Tzelepis","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2025.02.045_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","article-title":"An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells","volume":"53","author":"Kumagai","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2025.02.045_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.02.045_bib33","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.02.045_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2025.02.045_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2025.02.045_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745124","article-title":"SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer","volume":"19","author":"Chen","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jhep.2025.02.045_bib37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2025.02.045_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","article-title":"METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation","volume":"17","author":"Xue","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jhep.2025.02.045_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.26352","article-title":"Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatol (Baltimore, Md"},{"key":"10.1016\/j.jhep.2025.02.045_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174397","article-title":"ACSL family: the regulatory mechanisms and therapeutic implications in cancer","volume":"909","author":"Quan","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2025.02.045_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","article-title":"N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation","volume":"4","author":"Peng","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2025.02.045_bib42","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41388-023-02902-4","article-title":"RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1\/ACSL4","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"issue":"65","key":"10.1016\/j.jhep.2025.02.045_bib43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.28975","article-title":"Targeting beta-catenin in hepatocellular cancers induced by coexpression of mutant beta-catenin and K-Ras in mice","author":"Tao","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jhep.2025.02.045_bib44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:51:27Z","timestamp":1762260687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0168827825002065"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.045","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}